MTOR and breast carcinoma: In 2024, Ou et al. reported that the methylation of GPRC5A promotes liver metastasis (the third most common occurrence in distant metastasis of breast cancer) and docetaxel resistance via the mTOR signaling pathway in TNBC [29].